ClinicalTrials.gg
RecruitingNCT02073708Updated Nov 17, 2026

A Population-based Investigation of Asthma in the Telemark Region of Norway

An observational study in Obstructive Lung Diseases, Respiratory Symptoms and Inflammation, sponsored by Sykehuset Telemark. Recruiting at 1 site in Norway. Open to participants aged 16 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Sykehuset Telemark · Observational

How we know

From the registry’s dates

  • Started Feb 2018; still recruiting 8 years 9 months later.
Updated Nov 17, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
2,000
Ages
16 Years to 50 Years
Sex
All
01

Study summary

Respiratory conditions impose an enormous burden on the individual and the society. According to the WHO World Health Report 2000, the top five respiratory diseases - including asthma and COPD - account for 17% of all deaths and 13% of all Disability-Adjusted Life Years (DALYs). Obstructive lung diseases are among the most common chronic diseases in working-aged populations affecting \~40 million individuals in Europe. The greatest economic burden of respiratory diseases on health services and lost production in the EU is due to COPD and asthma, at about €20 billion each for healthcare and €25 billion and €15 billion, respectively, for lost production.

For Norway, there are no estimates of asthma prevalence for the country as a whole, but 80/1000 women and 55/1000 men used asthma medication in 2013 according to the national prescription register. Estimated annual deaths in Norway due to COPD were 4070 in 2015, which is 30% higher than for lung cancer. Unfortunately, a substantial proportion of patients are still difficult to treat. This underlines the need for better primary prevention and more knowledge regarding causes and exacerbating factors.

Several risk factors for chronic respiratory diseases are identified, most important tobacco smoke, closely followed by air pollution and occupational exposure. However, according to recent reviews there is a lack of understanding regarding environmental risk factors and mechanisms of how these affect respiratory health, the importance of biological markers and comorbidity, and of socioeconomic risk factors. Moreover, there is a need for assessment of interactions between risk factors and between the individual and the environment.

Telemark has a high proportion of craft- and industrial workers providing exposure contrasts. Furthermore, the use of medication against respiratory diseases and the rate of sick leave are higher in Telemark than elsewhere in Norway. Moreover, the county has a high rate of disability. There are previous studies from other parts of Norway, which have estimated the occurrence of respiratory diseases and provided valuable knowledge regarding some risk factors. However, these studies use crude measures of self-reported exposure and do not provide sufficient information on how to target intervention and implement effective prevention. In contrast to the Telemark study, these studies have not included register data or advanced modelling of environmental exposure.

Read the detailed description

Hypotheses and choice of methods:

Primary objective:

To identify preventive and health promoting measures for obstructive respiratory disease in a 5-year follow up of adults from the general population in Telemark.

Secondary objectives:

  • Identify occupational risk factors for obstructive respiratory disease
  • Assess interactions between risk factors and the individual
  • Transfer relevant knowledge and advice regarding preventive and health promoting measures to individuals, health care professionals and authorities.

Research problems/questions (Q):

Q1 What are the emerging occupational risk factors for respiratory health? Q2 What are the social inequity/socioeconomic factors predicting respiratory disease? Q3 How does HRQoL develop over time? Q4 Do risk factors interact and how do they relate to the individual? Q5 What is the population attributable risk (PAR) for the identified risk factors, and what are the key factors for better prevention and respiratory health promotion?

Choice of methods/work packages (WP) and approaches (A):

WP I Occupational risk factors Q1 Emerging occupational causes and risk factors for respiratory disease and exacerbation

  • A1.1 Assess associations between self-report of occupational exposure and new-onset and exacerbation of respiratory symptoms and diseases
  • A1.2 Assess associations between job-exposure-matrix data (JEM) and new-onset and exacerbation of respiratory symptoms and diseases

WP II Individual risk factors Q2 Risk factors for social inequity in respiratory health

  • A2.1 Assessment of the association between socio-demographic variables (gender, age, education, occupation and income) and respiratory health

WP III Complex interactions Q3 Health related quality of life development over time.

  • A3.1 Impact of respiratory health and disease development and treatment on HRQoL development Q4 Interactions between risk factors and the individual
  • A4.1 Identify interactions between risk factors and the individual by using advanced mathematical modelling Q5 The population attributable risk (PAR) for identified risk factors and key factors for better prevention and respiratory health promotion
  • A5.1 Calculate PAR for risk factors identified in WP1-3 separately and combined
  • A5.2 Based on PAR, estimate key factors for prevention and their cost
02

Conditions studied

  • Obstructive Lung Diseases
  • Respiratory Symptoms
  • Inflammation
03

In context

Lung Diseases, Obstructive

202 studies on the registry are indexed under Lung Diseases, Obstructive; 23 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 185 across 48 observational studies indexed under Lung Diseases, Obstructive.

Browse Lung Diseases, Obstructive studies →

Lead sponsor

Sykehuset Telemark is the lead sponsor of 33 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The researchers collected data in 2013 on respiratory symptoms and physician diagnosed asthma from 16.099 inhabitants of Telemark County (the cross-sectional baseline study called The Telemark-study I). A random sample from the baseline study of approximately 650 asthma cases and 650 controls were asked to take part in a medical examination in a case-control study in 2014-15.

The five year follow up of the baseline (The Telemark-study II) study was performed in 2018 and included 13500 subjects. The follow-up of the nested case-control study started in September 2018 and is on-going.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Physician diagnosed asthma
  • Controls without physician-diagnosed asthma

Exclusion criteria

Exclusion Criteria:

  • inability to fill-inn the questionnaire
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
2,000 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. The occurence of asthma and the association to specific occupational and environmental exposures and comorbidity

    Incidence and associations

    Time frame: Five years

Secondary outcomes

  1. Risk factors for the occurence of asthma symptoms in subjects with asthma symptoms but no asthma diagnosis

    Odds ratio

    Time frame: Five years

  2. Differences in lung function, FeNO and inflammatory markers in blood in asthma patients and the association of these changes to specific occupational and environmental exposures.

    Lung function indices, serum levels in blood

    Time frame: Five years

07

Study locations

1 of 1 sites recruiting
  • Telemark Hospital, dep. of Occupational and Environmental Medicine
    Skien, Telemark 3710, Norway
    Recruiting
    • Anne Kristin M. Fell, MD, PhD · Contactanne-kristin.fell@sthf.no · +4735004951
    • Anne Kristin M. Fell, MD, PhD · Principal investigator
    • Regine Abrahamsen, MD · Sub investigator
08

References and documents

Publications

  • Lillienberg L, Andersson E, Janson C, Dahlman-Hoglund A, Forsberg B, Holm M, Glslason T, Jogi R, Omenaas E, Schlunssen V, Sigsgaard T, Svanes C, Toren K. Occupational exposure and new-onset asthma in a population-based study in Northern Europe (RHINE). Ann Occup Hyg. 2013 May;57(4):482-92. doi: 10.1093/annhyg/mes083. Epub 2012 Dec 1. PubMed 23204511 ↗
  • de Vocht F, Zock JP, Kromhout H, Sunyer J, Anto JM, Burney P, Kogevinas M. Comparison of self-reported occupational exposure with a job exposure matrix in an international community-based study on asthma. Am J Ind Med. 2005 May;47(5):434-42. doi: 10.1002/ajim.20154. PubMed 15828067 ↗
  • Delclos GL, Gimeno D, Arif AA, Benavides FG, Zock JP. Occupational exposures and asthma in health-care workers: comparison of self-reports with a workplace-specific job exposure matrix. Am J Epidemiol. 2009 Mar 1;169(5):581-7. doi: 10.1093/aje/kwn387. Epub 2009 Jan 6. PubMed 19126585 ↗
  • Fell AKM, Svendsen MV, Kim JL, Abrahamsen R, Henneberger PK, Toren K, Blanc PD, Kongerud J. Exposure to second-hand tobacco smoke and respiratory symptoms in non-smoking adults: cross-sectional data from the general population of Telemark, Norway. BMC Public Health. 2018 Jul 6;18(1):843. doi: 10.1186/s12889-018-5771-4. PubMed 29980242 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2018 (actual). Primary completion is estimated for Jan 2035, 203 months after the start.

Of 25 observational studies under Lung Diseases, Obstructive, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 53. This study's planned 203 months is above that.

Primary completion moved once since we started tracking on Sep 25, 2026: Dec 2035 → Jan 2035, on Nov 17, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 20, 2014
First posted
Feb 27, 2014
StartActual
Feb 1, 2018
Primary completionEst.
Jan 31, 2035was Dec 2035
CompletionEst.
Dec 31, 2035
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Recruiting
changed Nov 17, 2026
Sites
Telemark Hospital, dep. of Occupational and Environmental Medicine is now Recruiting
Nov 17, 2026
Primary completion
Dec 31, 2035→Jan 31, 2035
Nov 17, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Telemark Hospital, dep. of Occupational and Environmental Medicine · Skien, NorwayContact added a•••@sthf.no · •••4951Contact added (no phone or email listed)Contact added (no phone or email listed)
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Active, not recruiting→Recruiting
    Telemark Hospital, dep. of Occupational and Environmental Medicine is now Recruiting
    Primary completion Dec 31, 2035→Jan 31, 2035
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Telemark Hospital, dep. of Occupational and Environmental Medicine · Skien, NorwayContact added a•••@sthf.no · •••4951Contact added (no phone or email listed)Contact added (no phone or email listed)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT02073708
Lead sponsor
Sykehuset Telemark
Collaborators
Oslo University Hospital, National Institute for Occupational Safety and Health (NIOSH/CDC), Göteborg University
Responsible party
Anne Kristin M. Fell (MD, PhD, Sykehuset Telemark) — Principal investigator
First posted
Feb 27, 2014
Start date
Feb 1, 2018
Primary completion
Jan 31, 2035 (estimated)
Completion
Dec 31, 2035 (estimated)
Last update
Nov 17, 2026

Study contacts

Johny Kongerud, Professor
study director · Oslo University, Oslo University Hospital
Anne Kristin Møller Fell, PhD
principal investigator · Sykehuset Telemark

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion